News
Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...
Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...
Opinion
1dOpinion
Zacks Investment Research on MSNEarly Q2 Results Indicate an Improving Earnings Outlook
We get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. The reporting docket expands beyond the Finance core, ...
1h
Zacks Investment Research on MSNPennyMac Financial (PFSI) Lags Q2 Earnings and Revenue Estimates
PennyMac Financial (PFSI) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.67 per share a year ago. These ...
In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...
Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results